925977-71-5

Basic information

• Product Name: [2-[1,3]dioxolan-2-yl-ethyl-1-(4-methoxybenzyl)]phosphonic acid diethyl ester
• Synonyms: [2-[1,3]dioxolan-2-yl-ethyl-1-(4-methoxybenzyl)]phosphonic acid diethyl ester
• CAS NO: 925977-71-5
• Molecular Weight: 358.372
• Mol File: 925977-71-5.mol

Chemical Properties

• CAS DataBase Reference: [2-[1,3]dioxolan-2-yl-ethyl-1-(4-methoxybenzyl)]phosphonic acid diethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [2-[1,3]dioxolan-2-yl-ethyl-1-(4-methoxybenzyl)]phosphonic acid diethyl ester(925977-71-5)
• EPA Substance Registry System: [2-[1,3]dioxolan-2-yl-ethyl-1-(4-methoxybenzyl)]phosphonic acid diethyl ester(925977-71-5)

Safety Data

• Hazardous Substances Data: 925977-71-5(Hazardous Substances Data)

Upstream product

• 17053-10-0 [2-(1,3-dioxolan-2-yl)ethyl]phosphonic acid diethyl ester 

Downstream Products

• 925978-01-4 2,2-dimethyl-propionic acid [3-(acetyl-benzyloxy-amino)-1-(4-methoxy-benzyl)-propyl]-(2,2-dimethyl-propionyloxymethoxy)-phosphinoyloxymethyl ester 
• 925977-95-3 2,2-dimethyl-propionic acid [3-(benzyloxy-formyl-amino)-1-(4-methoxy-benzyl)-propyl]-(2,2-dimethyl-propionyloxymethoxy)-phosphinoyloxymethyl ester 

Relevant articles and documents

Arylmethyl substituted derivatives of Fosmidomycin: Synthesis and antimalarial activity

The phosphonohydroxamic acid Fosmidomycin is a drug candidate for the treatment of Malaria, currently in phase II trials in combination with Clindamycin. In order to obtain compounds of higher lipophilicity, we recently synthesized α-phenyl substituted Fo